Chatterjee, Shambhabi
Leach-Mehrwald, Megan
Huang, Cheng-Kai
Xiao, Ke
Fuchs, Maximilian
Otto, Mandy
Lu, Dongchao
Dang, Vinh
Winkler, Thomas
Dunbar, Cynthia E.
Thum, Thomas
Bär, Christian http://orcid.org/0000-0001-9276-9383
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KFO311, BA5631/2-1, BA 5631/5-1)
European Research Council (Consolidator Grant-LongHEART)
NHLBI Division of Intramural Research
Medizinische Hochschule Hannover (HiLF-I)
Förderkreis Dresdener Herz-Kreislauf-Tage (DHKT-2024)
Medizinische Hochschule Hannover (MHH)
Article History
Received: 24 October 2023
Revised: 29 March 2024
Accepted: 12 April 2024
First Online: 24 April 2024
Declaration
:
: T.T. is co-founder and holds shares of Cardior Pharmaceuticals GmbH (outside of this paper). T.T. filed and licensed patents on noncoding RNAs (outside of this paper). C.B. has filed and licensed patents on the therapeutic use of AAV9-mediated delivery of telomerase (outside of this paper). The other authors declare no competing interests.